AbbVie Inc. Operating Income Loss

Quick Answer

AbbVie Inc. reported Operating Income Loss of $15.08 billion for the year ending 2025.

  • AbbVie Inc. showed an increase of +65.0% in Operating Income Loss from 2024 to 2025.
  • This data is from AbbVie Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2012: $978.00 million | Q2 2012: $1.42 billion | Q3 2012: $1.60 billion | Q1 2013: $1.31 billion | Q2 2013: $1.45 billion | Q3 2013: $1.37 billion | Q1 2014: $1.35 billion | Q2 2014: $1.52 billion | Q3 2014: $960.00 million | Q1 2015: $1.69 billion | Q2 2015: $1.85 billion | Q3 2015: $1.89 billion | Q1 2016: $2.28 billion | Q2 2016: $2.39 billion | Q3 2016: $2.36 billion | Q1 2017: $2.41 billion | Q2 2017: $2.66 billion | Q3 2017: $2.69 billion | Q1 2018: $2.90 billion | Q2 2018: $2.76 billion | Q3 2018: $3.16 billion | Q1 2019: $3.01 billion | Q2 2019: $3.40 billion | Q3 2019: $2.62 billion | Q1 2020: $3.60 billion | Q2 2020: $752.00 million | Q3 2020: $3.26 billion | Q1 2021: $4.10 billion | Q2 2021: $4.44 billion | Q3 2021: $4.31 billion | Q1 2022: $4.72 billion | Q2 2022: $3.30 billion | Q3 2022: $4.60 billion | Q1 2023: $2.77 billion | Q2 2023: $4.51 billion | Q3 2023: $2.28 billion | Q1 2024: $2.80 billion | Q2 2024: $4.00 billion | Q3 2024: $3.83 billion | Q1 2025: $3.73 billion | Q2 2025: $4.89 billion | Q3 2025: $1.90 billion.
  • Over the full 15 years of available data (2011 to 2025), AbbVie Inc.'s Operating Income Loss has grown by 316.4%.
  • Historical annual values: Fiscal year 2025: $15.08 billion | Fiscal year 2024: $9.14 billion | Fiscal year 2023: $12.76 billion | Fiscal year 2022: $18.12 billion | Fiscal year 2021: $17.92 billion | Fiscal year 2020: $11.36 billion | Fiscal year 2019: $12.98 billion | Fiscal year 2018: $6.38 billion | Fiscal year 2017: $9.55 billion | Fiscal year 2016: $9.34 billion | Fiscal year 2015: $7.54 billion | Fiscal year 2014: $3.41 billion | Fiscal year 2013: $5.66 billion | Fiscal year 2012: $5.82 billion | Fiscal year 2011: $3.62 billion.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: